These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39014499)

  • 1. Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis.
    Schumacher F; Zimmermann M; Kanbach M; Schulze W; Wollsching-Strobel M; Kroppen D; Stanzel SB; Majorski D; Windisch W; Strunk J; Berger M
    Arthritis Res Ther; 2024 Jul; 26(1):132. PubMed ID: 39014499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hočevar
    Lundberg IE; Bottai M; Tjärnlund A
    Ann Rheum Dis; 2018 Dec; 77(12):e91. PubMed ID: 29317406
    [No Abstract]   [Full Text] [Related]  

  • 5. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
    Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
    Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies.
    Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe rhabdomyolysis due to idiopathic inflammatory myopathies, a wary manifestation of a heterogenous pathology.
    Schepens N; Herroelen PH; Decavele AS; Vanacker A
    Acta Clin Belg; 2023 Apr; 78(2):160-164. PubMed ID: 35491881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance between clinical convenience and the new concepts of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Kim HS
    Korean J Intern Med; 2021 Mar; 36(2):288-291. PubMed ID: 33725435
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice.
    Hočevar A; Rotar Z; Krosel M; Čučnik S; Tomšič M
    Ann Rheum Dis; 2018 Dec; 77(12):e90. PubMed ID: 29237619
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
    So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
    Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
    Leclair V; Lundberg IE
    Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?
    Malaviya AN
    Ann Rheum Dis; 2018 Nov; 77(11):e77. PubMed ID: 29170201
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya.
    Lundberg IE; Tjärnlund A
    Ann Rheum Dis; 2018 Nov; 77(11):e78. PubMed ID: 29247124
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study.
    Al Nokhatha SA; Alfares E; Corcoran L; Conlon N; Conway R
    Rheumatol Int; 2021 Dec; 41(12):2133-2146. PubMed ID: 34608531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.
    Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Garcia-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
    Arthritis Rheumatol; 2017 Dec; 69(12):2271-2282. PubMed ID: 29106061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
    Yamasaki Y; Kobayashi N; Akioka S; Yamazaki K; Takezaki S; Nakaseko H; Ohara A; Nishimura K; Nishida Y; Sato S; Kishi T; Hashimoto M; Mori M; Okazaki Y; Kuwana M; Ohta A
    Rheumatology (Oxford); 2021 Oct; 60(10):4821-4831. PubMed ID: 33576399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.